Emlily Mlynarek
Physician Assistant · Royal Oak, MINPI 1306579727
Payments from drug & device makers
Across 407 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Takeda Pharmaceuticals U.S.A., Inc.$892
- GSK$848
- Sanofi$738
- Regeneron Healthcare Solutions, Inc.$702
- CSL Behring$599
- plus $3K from 24 others
What the payments were for
- Food & beverage$8,78197%
- Education$2273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 95 | $2,186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $892 |
| GSK | 64 | $848 |
| Sanofi | 34 | $738 |
| Regeneron Healthcare Solutions, Inc. | 27 | $702 |
| CSL Behring | 24 | $599 |
| Optinose US, Inc. | 25 | $598 |
| Amgen | 23 | $397 |
| Pharming Healthcare, Inc. | 13 | $304 |
| Galderma Laboratories, L.p. | 9 | $241 |
| Pfizer | 8 | $239 |
| Kaleo, Inc. | 9 | $154 |
| Alk-abello, Inc | 8 | $150 |
| Novartis | 6 | $148 |
| Organon | 2 | $135 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $93 |
| Biocryst US Sales Co., LLC | 3 | $90 |
| LEO Pharma Inc. | 4 | $80 |
| Genentech USA, Inc. | 4 | $78 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Hospira, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $35 |
| Octapharma USA, Inc. | 1 | $26 |
| Blueprint Medicines Corporation | 1 | $20 |
| Dermavant Sciences, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Covis Pharma GmbH | 1 | $14 |
| AbbVie | 1 | $14 |
| Grifols USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,008 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 62 | $47,514 |
| Spiriva RespimatTiotropium Bromide | 34 | $25,604 |
| Breo ElliptaFluticasone/Vilanterol | 34 | $16,429 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $10,033 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 32 | $8,677 |
| Epinephrine | 23 | $6,327 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 32 | $6,268 |
| Azelastine Hcl | 175 | $5,820 |
| DuleraMometasone/Formoterol | 11 | $3,607 |
| Montelukast Sodium | 212 | $2,941 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $2,636 |
| Wixela InhubFluticasone Propion/Salmeterol | 19 | $2,355 |
| Fluticasone Propionate | 160 | $2,302 |
| Ventolin HfaAlbuterol Sulfate | 22 | $1,387 |
| Ipratropium Bromide | 49 | $1,340 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $848 | $63,94396 claims |
| AstraZenecaBreztri Aerosphere | $2,186 | $10,03314 claims |
| Hikma Pharmaceuticals USAEpinephrine | $15 | $6,32723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Royal Oak
- Sarang PatelRoyal Oak$660K
- Gabrielle DamoreRoyal Oak$200K
- Laura KingRoyal Oak$63K
- Inge HanschuRoyal Oak$21K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.